Ongoing Surveillance During Treatment Once peptide therapy is initiated, ongoing surveillance for malignancy should continue throughout the treatment period and potentially beyond, depending on treatment duration and individual risk factors
Semaglutide, when used outside of pregnancy, reduces appetite, leading to fewer calories consumed and, ultimately, weight loss
Pathogenesis of idiopathic pulmonary fibrosis
What to Track Each Week Weekly tracking plays a key role in recognizing patterns, understanding whats effective, and addressing potential issues before they escalate
The most common side effects are gastrointestinal (nausea, vomiting, diarrhoea, constipation), with mood disturbances not listed as recognised adverse reactions in the Summary of Product Characteristics
No significant sex- or weight-based risks were noted for liraglutide or tirzepatide